Search for: "PLIVA, Inc. v. Mensing" Results 41 - 60 of 230
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Apr 2014, 9:29 am by Ronald Mann
  To be sure, the Court has barred suits against generic manufacturers in two decisions following up on Wyeth (PLIVA, Inc. v. [read post]
10 Apr 2014, 11:58 am
Janssen Pharmaceuticals, Inc., 2014 WL 1335511 (Pa. [read post]
27 Mar 2014, 5:00 am
Ct. 2492, 2504-05 (2012) (“the existence of an express pre-emption provision does not bar the ordinary working of conflict pre-emption principles or impose a special burden that would make it more difficult to establish the preemption of laws falling outside the clause”); PLIVA, Inc. v. [read post]
13 Feb 2014, 7:47 am by m zamora
Pliva, Inc., currently pending in the U.S. [read post]
3 Feb 2014, 5:00 am
Levine, 555 U.S. 555 (2009), and weaponized by our side in PLIVA v. [read post]
4 Dec 2013, 2:38 pm by Colter Paulson
Wyeth Pharms., Inc., decided this Monday, the Sixth Circuit affirmed the complete dismissal of claims against makers of generic drugs under the Supreme Court’s decisions in PLIVA, Inc. v. [read post]
6 Sep 2013, 8:10 am by Steven Boranian
We all know that failure-to-warn and design defect claims against generic drug manufacturers are preempted, thanks to PLIVA, Inc. v. [read post]
5 Sep 2013, 12:24 pm by Bexis
PLIVA, Inc., 711 F.3d 578, 584-85 (6th Cir. 2013) (generic drugs); Ray v. [read post]
30 Jul 2013, 2:01 pm by Bexis
Lexis 1688, at *36) to Merrell Dow Pharmaceuticals, Inc. v. [read post]